Avinger Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Avinger has been growing earnings at an average annual rate of 4.6%, while the Medical Equipment industry saw earnings growing at 12.9% annually. Revenues have been declining at an average rate of 3.1% per year.
Belangrijke informatie
4.6%
Groei van de winst
79.8%
Groei van de winst per aandeel
| Medical Equipment Groei van de industrie | 8.9% |
| Inkomstengroei | -3.1% |
| Rendement op eigen vermogen | -250.0% |
| Nettomarge | -206.5% |
| Volgende winstupdate | 07 Nov 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Avinger GAAP EPS of -$0.94 beats by $0.15, revenue of $2.13M misses by $0.25M
Aug 11Is Avinger (NASDAQ:AVGR) Using Debt Sensibly?
Nov 25
Is Avinger (NASDAQ:AVGR) A Risky Investment?
Jun 30Avinger shares fall after Q1 results fail to impress Wall Street
May 07Does Avinger (NASDAQ:AVGR) Have A Healthy Balance Sheet?
Jan 21
Avinger 'Hot Penny Stock to buy' - Robinhood
Jan 08Opbrengsten en kosten
Hoe Avinger geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 7 | -15 | 15 | 4 |
| 31 Mar 24 | 8 | -16 | 15 | 4 |
| 31 Dec 23 | 8 | -18 | 14 | 5 |
| 30 Sep 23 | 8 | -19 | 14 | 5 |
| 30 Jun 23 | 8 | -22 | 14 | 5 |
| 31 Mar 23 | 8 | -22 | 14 | 5 |
| 31 Dec 22 | 8 | -27 | 14 | 4 |
| 30 Sep 22 | 9 | -28 | 15 | 5 |
| 30 Jun 22 | 9 | -29 | 15 | 5 |
| 31 Mar 22 | 9 | -27 | 16 | 5 |
| 31 Dec 21 | 10 | -22 | 16 | 6 |
| 30 Sep 21 | 10 | -21 | 16 | 6 |
| 30 Jun 21 | 10 | -21 | 15 | 6 |
| 31 Mar 21 | 9 | -22 | 14 | 6 |
| 31 Dec 20 | 9 | -23 | 14 | 6 |
| 30 Sep 20 | 9 | -23 | 15 | 6 |
| 30 Jun 20 | 9 | -23 | 15 | 6 |
| 31 Mar 20 | 10 | -24 | 17 | 6 |
| 31 Dec 19 | 9 | -23 | 17 | 6 |
| 30 Sep 19 | 9 | -24 | 17 | 6 |
| 30 Jun 19 | 8 | -25 | 18 | 6 |
| 31 Mar 19 | 8 | -26 | 18 | 6 |
| 31 Dec 18 | 8 | -36 | 18 | 6 |
| 30 Sep 18 | 8 | -39 | 18 | 6 |
| 30 Jun 18 | 8 | -43 | 19 | 7 |
| 31 Mar 18 | 8 | -49 | 20 | 9 |
| 31 Dec 17 | 10 | -49 | 25 | 11 |
| 30 Sep 17 | 13 | -52 | 29 | 13 |
| 30 Jun 17 | 16 | -55 | 34 | 15 |
| 31 Mar 17 | 18 | -55 | 37 | 15 |
| 31 Dec 16 | 19 | -56 | 40 | 16 |
| 30 Sep 16 | 17 | -56 | 40 | 15 |
| 30 Jun 16 | 15 | -56 | 38 | 16 |
| 31 Mar 16 | 13 | -53 | 35 | 16 |
| 31 Dec 15 | 11 | -50 | 29 | 16 |
| 30 Sep 15 | 11 | -44 | 25 | 15 |
| 30 Jun 15 | 11 | -40 | 23 | 13 |
| 31 Mar 15 | 11 | -37 | 21 | 12 |
| 31 Dec 14 | 11 | -32 | 19 | 11 |
| 30 Sep 14 | 12 | -32 | 18 | 12 |
| 30 Jun 14 | 12 | -33 | 20 | 12 |
| 31 Mar 14 | 12 | -37 | 23 | 14 |
| 31 Dec 13 | 13 | -40 | 26 | 16 |
Kwaliteitswinsten: AVGR is currently unprofitable.
Groeiende winstmarge: AVGR is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: AVGR is unprofitable, but has reduced losses over the past 5 years at a rate of 4.6% per year.
Versnelling van de groei: Unable to compare AVGR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: AVGR is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.7%).
Rendement op eigen vermogen
Hoge ROE: AVGR has a negative Return on Equity (-249.95%), as it is currently unprofitable.